| HOME >> BIOLOGY >> TECHNOLOGY |
Cash and Cash Equivalents at End of Period $866 $1,460
Monsanto Company
Selected Financial Information
(Dollars in millions)
Unaudited
(1) All earnings per share figures have been adjusted to reflect the
company's two-for-one stock split which was paid on July 28, 2006, in
the form of a 100 percent stock dividend.
(2) EBIT, Ongoing EPS and Free Cash Flow: The presentations of EBIT,
ongoing EPS and free cash flow are not intended to replace net income
(loss), cash flows, financial position or comprehensive income
(loss), and they are not measures of financial performance as
determined in accordance with generally accepted accounting
principles (GAAP) in the United States. The following tables
reconcile EBIT, ongoing EPS and free cash flow to the respective most
directly comparable financial measure calculated in accordance with
GAAP.
Reconciliation of EBIT to Net Income (Loss): EBIT is defined as
earnings (loss) before interest and taxes. Earnings (loss) is
intended to mean net income (loss) as presented in the Statements of
Consolidated Operations under GAAP. The following table reconciles
EBIT to the most directly comparable financial measure, which is net
income (loss).
Three Months 12 Months
Ended Ended
Aug. 31 Aug. 31,
2007 2006 2007 2006
EBIT - Seeds and Genomics Segment $(397) $(228) $905 $794
EBIT - Agricultural Productivity
Segment
'/>"/>
| SOURCE Monsanto Copyright©2007 PR Newswire. All rights reserved |